European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesRobert Knobler, Thomas Krieg, Alain Taı̈eb et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 261
Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysisMarzia Caproni, Paolo Fabbri, Daniele Torchia et al.|British Journal of Dermatology|2006Cited by 136
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Antonio Costanzo, Alessandra Narcisi et al.|Frontiers in Medicine|2023Cited by 55
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)Diego Orsini, Antonio Costanzo, Piergiorgio Malagoli et al.|Dermatology Practical & Conceptual|2024Cited by 34